1.Станков Д.С., Катунян П.И., Крашенинников М.Е., Онищенко Н.А. Нейротрансплантация в лечении травмы спинного мозга. Вестник трансплантологии и искусственных органов 2003; 1: 44-52.2.Cyranoski D. Patients warned about unproven spinal surgery. Nature 2006; 440; 850-1.3.Huang H., Chen L., Wang H. et al. Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin. Med. [Engl) 2003; 116: 1488-9.4.Steeves J.D., Fawcett J., Tuszynski M. Report of international clinical trials workshop on spinal cord injury February 20-21,2004. Spinal Cord 2004; 42: 591-7.5.Cyranoski D. Paper chase. Nature 2005; 437: 810-1.6.Curt A., Dietz V. Controversial treatments for spinal cord injuries - first reply [correspondence]. Lancet 2005; 5: 841.7.Guest J., Herrera L., Qian T. Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb- derived cells. Spinal Cord 2006; 44[3): 135-42.8.Anstett P. We have to overcome this hope barrier. Detroit Free Press, June 7, 2005.9.Anderson D., Beattie M., Blesch A. et al. Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord 2005; 43: 453-8.10.Rosenberg R.N. World Federation of Neurology position paper on human stem cell research. J. Neurol. Sci. 2006; 243[1 -2): 1 -2.